Verici Dx (LON:VRCI) Shares Down 8.6% – Here’s What Happened

Verici Dx plc (LON:VRCI) was down 8.6% during mid-day trading on Wednesday . The stock traded as low as GBX 0.45 and last traded at GBX 0.48. Approximately 2,220,681 shares changed hands during mid-day trading, an increase of 50% from the average daily volume of 1,484,795 shares. The stock had previously closed at GBX 0.53.

Verici Dx Price Performance

The stock has a 50-day moving average price of GBX 0.61 and a 200 day moving average price of GBX 0.70. The company has a debt-to-equity ratio of 11.36, a current ratio of 0.91 and a quick ratio of 8.49. The firm has a market cap of £7.26 million, a price-to-earnings ratio of -0.17 and a beta of 1.52.

About Verici Dx

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.